The estimated Net Worth of Robert M Davis is at least $57.4 Milion dollars as of 13 February 2024. Mr. Davis owns over 235,021 units of Merck & Co Inc stock worth over $49,709,234 and over the last 19 years he sold MRK stock worth over $0. In addition, he makes $7,727,190 as Executive Vice President, Global Services oraz Chief Financial Officer at Merck & Co Inc.
Robert has made over 10 trades of the Merck & Co Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 235,021 units of MRK stock worth $17,396,254 on 13 February 2024.
The largest trade he's ever made was exercising 251,273 units of Merck & Co Inc stock on 5 October 2020 worth over $28,823,526. On average, Robert trades about 23,865 units every 91 days since 2006. As of 13 February 2024 he still owns at least 433,347 units of Merck & Co Inc stock.
You can see the complete history of Mr. Davis stock trades at the bottom of the page.
Robert M. Davis serves as Executive Vice President, Global Services, Chief Financial Officer of the Company. (October 2010-March 2014) Mr. Davis is responsible for the Company’s global financial organization, investor relations, corporate strategy and business development, global facilities, and the Company’s joint venture relationships. Prior to starting his employment with the Company, Mr. Davis served as Corporate Vice President and President, Medical Products of Baxter International, Inc. (“Baxter”), a healthcare company, a position he had held since October 2010. In that position, Mr. Davis was responsible for all aspects of commercial, R&D, quality, regulatory, manufacturing and supply chain functions. Prior to that position, Mr. Davis served as Corporate Vice President and President, Renal Division of Baxter in 2010 and had previously served as Baxter’s Corporate Vice President and Chief Financial Officer from 2006 to 2010.
As the Executive Vice President, Global Services oraz Chief Financial Officer of Merck & Co Inc, the total compensation of Robert Davis at Merck & Co Inc is $7,727,190. There are 2 executives at Merck & Co Inc getting paid more, with Kenneth Frazier having the highest compensation of $27,648,500.
Robert Davis is 53, he's been the Executive Vice President, Global Services oraz Chief Financial Officer of Merck & Co Inc since 2016. There are 22 older and 4 younger executives at Merck & Co Inc. The oldest executive at Merck & Co Inc is Thomas Cech, 73, who is the Independent Director.
Robert's mailing address filed with the SEC is 525 S. TRYON STREET, , CHARLOTTE, NC, 28202.
Over the last 15 years, insiders at Merck & Co Inc have traded over $138,980,380 worth of Merck & Co Inc stock and bought 48,209 units worth $1,563,736 . The most active insiders traders include Wendell P Weeks, Kenneth C Frazier oraz Douglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of $5,050,222. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth $4,250,995.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Merck & Co Inc executives and other stock owners filed with the SEC include: